Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cause and prevention of demyelination in a model multiple sclerosis lesion.
Visual evoked potentials in neuromyelitis optica and its spectrum disorders.
The molecular study of IFNβ pleiotropic roles in MS treatment.
Low dose cyclophosphamide effectively mobilizes peripheral blood stem cells in patients with autoimmune disease.
Stratified mixture modeling for segmentation of white-matter lesions in brain MR images.
Cutting Edge: Nanogel-Based Delivery of an Inhibitor of CaMK4 to CD4+ T Cells Suppresses Experimental Autoimmune Encephalomyelitis and Lupus-like Disease in Mice.
Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid.
Multiple Sclerosis and Experimental Allergic Encephalomyelitis.
Dextromethorphan/Quinidine for the treatment of pseudobulbar affect.
Deep grey matter involvement in multiple sclerosis: key player or bystander?
Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosis.
[Diagnosis and monitoring of multiple sclerosis : The value of optical coherence tomography.]
[Alemtuzumab is a new drug based on monoclonal antibodies for treatment multiple sclerosis: treatment possibilities and risks(review)].
Correction: MRI Correlates of Disability in African-Americans with Multiple Sclerosis.
Features of Human CD3+CD20+ T Cells.
Unaltered regulatory B-cell frequency and function in patients with multiple sclerosis.
Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis.
Detection of JCPyV microRNA in blood and urine samples of multiple sclerosis patients under natalizumab therapy.
Variables Related to Working Capability among Swiss Patients with Multiple Sclerosis-A Cohort Study.
Kaposi sarcoma in a patient with relapsing-remitting multiple sclerosis receiving fingolimod.
SOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune Function.
The Relationship Between Balance Confidence and Cognitive Motor Interference in Individuals With Multiple Sclerosis.
Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis.
Dynamics of brain iron levels in multiple sclerosis: A longitudinal 3T MRI study.
An updated role of microRNA-124 in central nervous system disorders: a review.
Pages
« first
‹ previous
…
587
588
589
590
591
592
593
594
595
…
next ›
last »